Arcturus Therapeutics Holdings Inc
ARCT
Equity
ISIN null / Valor 48461643
NASDAQ (2026-01-16)
USD 7.29-4.20%
Arcturus Therapeutics Holdings Inc
UMushroom community rating:
About company
Arcturus Therapeutics Holdings Inc is a biopharmaceutical company that focuses on the development of RNA-based therapeutics for the treatment of various diseases.
Summarized from source with an LLMView SourceSector: FinanceKey figures
-57.1%1Y
-63.3%3Y
-87.8%5Y
Performance
108%1Y
86.7%3Y
101%5Y
Volatility
207 M
Market cap (USD)
419,684
Daily traded volume (Shares)
16.91 / 16.03
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
0.002022
0.002023
0.002024
Est dividend (USD)
0.00%2022
0.00%2023
0.00%2024
Est dividend yield
P/E ratio
00.002022
00.002023
00.002024
Est P/E ratio
EPS (USD)
0.002022
0.002023
0.002024
Est EPS (USD)
Ratings & reviews
Performance:
3.11
Innovation:
3.67
Society:
3.57
Nature:
3.43
Loic Lienard
Arcturus Therapeutics is a highly innovative biotech company focused on mRNA-based vaccines and treatments. Although still volatile and in early stages, it shows strong potential for long-term growth in the biotechnology and healthcare sectors.
Robert Higley
Heavy buy on this for the long run
William Frost
Bad trend
EQUITIES OF THE SAME SECTOR
